These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15461545)

  • 1. Topical 0.05% cyclosporin in the treatment of dry eye.
    Perry HD; Donnenfeld ED
    Expert Opin Pharmacother; 2004 Oct; 5(10):2099-107. PubMed ID: 15461545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of topical cyclosporine for the treatment of dry eye disease.
    Perry HD; Solomon R; Donnenfeld ED; Perry AR; Wittpenn JR; Greenman HE; Savage HE
    Arch Ophthalmol; 2008 Aug; 126(8):1046-50. PubMed ID: 18695097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Clinical Efficacy and Safety of a Novel Cyclosporin A Nanoemulsion in the Treatment of Dry Eye Syndrome.
    Kim HS; Kim TI; Kim JH; Yoon KC; Hyon JY; Shin KU; Choi CY
    J Ocul Pharmacol Ther; 2017 Sep; 33(7):530-538. PubMed ID: 28759302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye.
    Gehlsen U; Braun T; Notara M; Krösser S; Steven P
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):767-775. PubMed ID: 28091781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy.
    Su MY; Perry HD; Barsam A; Perry AR; Donnenfeld ED; Wittpenn JR; D'Aversa G
    Cornea; 2011 Oct; 30(10):1098-104. PubMed ID: 21407074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.
    Kim YJ; Ryu JS; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Oh JY
    Cornea; 2016 Apr; 35(4):536-42. PubMed ID: 26807900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye: comment.
    Tam PM; Young AL; Lam PT
    Clin Exp Ophthalmol; 2010 Jan; 38(1):84-5. PubMed ID: 20447110
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical cyclosporine-A in dry eye associated with chronic graft versus host disease.
    Kurt RA; Yalçindag N; Atilla H; Arat M
    Ann Ophthalmol (Skokie); 2009; 41(3-4):166-9. PubMed ID: 20214049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Randomized Trial Comparing Efficacy of Topical Loteprednol Etabonate 0.5% Versus Cyclosporine-A 0.05% for Treatment of Dry Eye Syndrome Following Hematopoietic Stem Cell Transplantation.
    Boynton GE; Raoof D; Niziol LM; Hussain M; Mian SI
    Cornea; 2015 Jul; 34(7):725-32. PubMed ID: 25850708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry eye diagnosis and management in 2004.
    Perry HD; Donnenfeld ED
    Curr Opin Ophthalmol; 2004 Aug; 15(4):299-304. PubMed ID: 15232468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical cyclosporine a treatment in corneal refractive surgery and patients with dry eye.
    Torricelli AA; Santhiago MR; Wilson SE
    J Refract Surg; 2014 Aug; 30(8):558-64. PubMed ID: 25325897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical cyclosporine in thyroid orbitopathy-related dry eye: clinical findings, conjunctival epithelial apoptosis, and MMP-9 expression.
    Gürdal C; Genç I; Saraç O; Gönül I; Takmaz T; Can I
    Curr Eye Res; 2010 Sep; 35(9):771-7. PubMed ID: 20795858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine.
    Iaccheri B; Torroni G; Cagini C; Fiore T; Cerquaglia A; Lupidi M; Cillino S; Dua HS
    Eye (Lond); 2017 May; 31(5):788-794. PubMed ID: 28157225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic implications of topical cyclosporin A for the treatment of dry eye.
    Cross WD; Lay LF; Walt JG; Kozma CM
    Manag Care Interface; 2002 Sep; 15(9):44-9. PubMed ID: 12244650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of topical cyclosporine A on clinical findings and cytological grade of the disease in patients with dry eye.
    Sahli E; Hoşal BM; Zilelioğlu G; Gülbahçe R; Ustün H
    Cornea; 2010 Dec; 29(12):1412-6. PubMed ID: 20847673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine 0.05% ophthalmic emulsion for the treatment of radiation-associated dry eye in children.
    Hoehn ME; Kelly SR; Wilson MW; Walton RC
    Pediatr Blood Cancer; 2013 Jul; 60(7):E35-7. PubMed ID: 23335290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical review: topical ophthalmic use of cyclosporin A.
    Utine CA; Stern M; Akpek EK
    Ocul Immunol Inflamm; 2010 Oct; 18(5):352-61. PubMed ID: 20735287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.
    Sall K; Stevenson OD; Mundorf TK; Reis BL
    Ophthalmology; 2000 Apr; 107(4):631-9. PubMed ID: 10768324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.